AstraZeneca and Amgen’s Tezspire has met both co-primary and key [...]

AB2 Bio will receive $30 million from Nippon Shinyaku after [...]

Nucleome Therapeutics has strengthened its intellectual property portfolio after the [...]

Resolution Therapeutics has expanded its regenerative macrophage therapy pipeline with [...]

Gesynta Pharma has randomised half of the planned patients in [...]

Nucleome Therapeutics has appointed Michelle Morrow as chief scientific officer, [...]

Nucleome Therapeutics and Oxford University scientists have mapped the 3D [...]